Ovarian Cancer Trial, Not Yet Recruiting NCT07639801 Sponsor: Peking University Cancer Hospital & Institute Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Not Yet Recruiting

NCT07639801
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 75 years old.
  • People with a suspected or confirmed solid tumour, such as prostate cancer, liver cancer (hepatocellular carcinoma), ovarian cancer, or endometrial cancer.
  • People who are already scheduled to have a tumour biopsy or surgery within the next 2 months.
  • People who are generally well enough to carry out normal daily activities with little or no limitation (this is measured using a medical scale called ECOG; scores of 0 or 1 are required — confirm with trial site if unsure where a person falls on this scale).
  • People with an expected survival of at least 12 weeks.
  • People whose blood counts and organ function meet the required levels, specifically: enough white blood cells or infection-fighting cells (neutrophils); enough platelets (cells that help blood clot); haemoglobin (a measure of red blood cell health) at an adequate level; liver function test results within an acceptable range; and kidney function within an acceptable range.
  • People who have at least one tumour that can be measured using standard imaging guidelines (known as RECIST 1.1 criteria — confirm with trial site).
  • People who are able to understand what the study involves and are willing to sign a consent form.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with severely reduced liver or kidney function.
  • People who are unable to lie flat on their back for around 30 minutes during a PET/CT scan.
  • People who are unwilling or unable to take part in the clinical study.
  • People with claustrophobia (fear of enclosed spaces) or a severe mental health condition that would interfere with the imaging procedures.
  • People who have any other health condition that the study doctor considers would make participation unsuitable.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 1 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Peking University Cancer Hospital & Institute
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
31 December 2026

Primary endpoints

Standardized Uptake Value (SUV) of Tumor Lesions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov